• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Northern Ireland-Based Almac Group Expands Montgomery County, Pennsylvania, North American Headquarters

Northern Ireland-based Almac Group, a global contract pharmaceutical developer and manufacturer, is expanding its North American headquarters in Montgomery County, Pennsylvania. The $93.5 million project is expected to create 355 jobs over the next three years.

The expansion will add 100,000 square feet to the existing 246,000-square-foot facility in Souderton, including upgrades at the company’s sites in Audubon and Lansdale. The company has held operations in Pennsylvania for more than 20 years.

“We are delighted to mark this next milestone of our future in Montgomery County,” said Alan Armstrong, Almac Group chairman and chief executive. “We look forward to welcoming over 350 new employees, who will be an essential part of our continued success over the next three years. Almac Group’s mission is to advance human health and we are committed to re-investing all of our profits back into the business to ensure we are market leading for our clients and patients and offer the best possible work environment for our people.”

Almac Group received a funding proposal as an incentive from the Pennsylvania Department of Community and Economic Development (DCED) for a $1.775 million Pennsylvania First grant and a $250,000 workforce development (WEDnet) grant and were encouraged to apply for the department’s Manufacturing Tax Credit (MTC) and Research and Development Tax Credit (R&D) programs.

“This GAT project represents a huge capital investment, one of the largest in Montgomery County in recent years,” said DCED Acting Secretary Neil Weaver. “DCED is proud to invest in the Almac Group’s headquarters expansion and the good paying jobs that are being created and retained here in Pennsylvania.”

Almac Group is a global company based in Northern Ireland that is at the forefront of developing, manufacturing, testing, and distributing essential medicines to vulnerable patients around the world. During this financial year, the group was a partner of choice in the development of over 300 life-saving drugs spanning more than 20 therapeutic areas including oncology, cardiology, immunology, gene therapy and neurology.

“Almac’s exciting new phase of growth in Montgomery County is a testament to the excellent workforce and exceptional quality of life our communities offer,” said David Zellers, Jr., director of commerce, Montgomery County Commerce Department. “Everyone on the Montco team is appreciative of our partnership with GAT and DCED; working together county and state economic development leaders make for a winning team to keep investment and growth happening to the benefit all Pennsylvanians.”

Exclusive Research